| Ytd | 6.77% | |
| 1y | -16.89% |
| Open | 62.25 | Prev Close | 64.04 | Low | 60.58 | High | 64.55 | Mkt Cap | 11.38B |
| Vol | 7.16M | Avg Vol | 6.69M | EPS | -1.44 | P/E | N/A | Forward P/E | -4148.03 |
| Beta | 3.58 | Short Ratio | 6.10 | Inst. Own | 59.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 54.44 | 200-d Avg | 56.56 | 1yr Est | 63.36 |
Freedom Capital Markets analyst Gene Mannheimer maintains Tempus AI (NASDAQ:TEM) with a Hold and
Wood is known for being a tech-first investor.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and
Ark Invest bought roughly $17 million in Cerebras shares Tuesday, Aug. 25, 2026, while trimming its
Tempus AI Inc (NASDAQ:TEM) stock is trading lower on Monday as the stock is pulling back from an app
Tempus AI stock pulls back after a 20% surge as cancer data spotlights its Personalis deal, and FDA
US equities mixed as tech stocks drag Nasdaq 100 lower, Trump escalates trade fight with Canada, and
These leveraged ETFs surged last week as biotech, AI, crypto and Bitcoin-linked stocks rallied despi
Tempus AI, Inc. (NASDAQ:TEM) today announced it has received 510(k) clearance from the U.S. Food and
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced it has received 510(k) clear
Tempus AI stock surged this week after Merck and Moderna published encouraging trial results for a c
Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-d
The transaction involved 3,000 shares with a value of $161,700 on August 14. The sale reduced West's
Polovin executed the sale of 30,075 shares between August 18 and August 19, generating approximately
These 6,175 shares were disposed of at a weighted average price of $49.61 per share, for a total tra
The transaction involved 48,842 shares with an estimated value of about $2.7 million. This was a non
The transactions involved 17,314 shares at a weighted average price of $53.71 per share, totaling $9
The transaction involved 41,095 shares executed at a weighted average price of $49.61 per share, rep
The disposition of 133,000 shares was executed at a weighted average price of $49.61 per share, repr
Tempus AI, Inc. (NASDAQ: TEM - Get Free Report) shares traded up 8.3% during mid-day trading on Frid
Tempus AI Inc. (NASDAQ:TEM) shares are trading higher on Friday as traders continue to digest the la
Tempus AI is trading higher Friday as traders digest the latest follow-through from this week’s Merc
Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in fou
Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX,
Tempus AI (TEM) trades higher after positive Phase 3 mRNA cancer trial results spotlight its $1.5B a
Tempus AI remains a strong buy, driven by its unique flywheel business model and recent validation o
BTIG analyst Mark Massaro maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target
Bank of America Corp DE lessened its holdings in shares of Tempus AI, Inc. (NASDAQ: TEM) by 63.6% du
Healthcare stocks saw mixed after-hours moves, with Moderna and Merck cooling after explosive gains
Tempus AI (TEM) stock ripped higher on August 19 as third-party clinical breakthroughs triggered a t
$1.5 billion. That is what Tempus AI (NASDAQ:TEM | TEM Price Prediction) agreed to pay for Personali
Treasury's expanded long-bond buybacks knocked yields off 20-month highs and sank the dollar, as
Shares of Tempus AI are surging Wednesday morning as traders connected the dots between a landmark c
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting str
Tempus AI Inc. (NASDAQ: TEM) stock jumped on Friday, August 7, 2026, following strong AI healthcare
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within
Piper Sandler analyst David Westenberg maintains Tempus AI (NASDAQ:TEM) with a Neutral and lowers
PRISM2 outperformed or matched existing slide-level foundation models across a comprehensive set of
BTIG analyst Mark Massaro maintains Tempus AI (NASDAQ:TEM) with a Buy and lowers the price target
HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and lowers th
Stifel analyst Daniel Arias maintains Tempus AI (NASDAQ:TEM) with a Hold and lowers the price tar
The ARKK ETF continued its sell-off last week as investors continued dumping Cathie Wood's flags
AI infrastructure spending dominates markets as Apple, Amazon, Microsoft and semiconductor companies
Tempus AI Inc. (NASDAQ: TEM) shares are trading lower Friday as traders digest post-earnings reset i
Tempus AI stock is trading lower Thursday after Q2 results. This could be the reason.
Tempus AI (NASDAQ:TEM) raises FY2026 sales outlook from $1.590 billion-$1.600 billion to $1.595 bill
Tempus AI (NASDAQ:TEM) reported quarterly losses of $(0.04) per share which beat the analyst consens
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo
Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision m
Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full de